GenScript is a world-leading provider of cutting-edge technologies, unparalleled products, and renowned custom services that support life sciences research. Headquartered in New Jersey, with subsidiaries in Europe, Japan, and China, GenScript provides top research services to the global scientific community. Our extensive products portfolio ranges from validated antibodies, cytokines, stable cell lines, surface marker-based cell separation, protein purification magnetic beads, to PCR, gene cloning and gene editing reagents and kits.
We provide off-the-shelf reagents and kits that automate protein analysis processes such as PAGE gel staining, and western blotting. Our innovative magnetic purification technology provides reagents and instruments for automated recombinant protein purification (AmMagTM purification technology) and marker-assisted cell separation (CytoSinctTM cell separation technology). During the ongoing public health emergency generated by the COVID-19 pandemic, GenScript has stepped up and supported scientists and community leaders worldwide by developing key products such as SARS-CoV-2 qRT-PCR detection assays, viral gene-expressing stable cells lines, and more. GenScript’s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit is the first FDA-EUA authorized kit that specifically detects virus-blocking antibodies in patients’ blood. With such groundbreaking new technologies and an unmitigated commitment to excellence, GenScript helps scientists all over the world accelerate their research.
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. Personalis also provides genomic information to the VA Million Veterans Program as part of their goal to sequence over a million veteran genomes. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).
We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and
cellular therapy. For over 25 years, our innovative tools have been used to obtain, analyze, and
utilize cells. 2,000 employees in 15 international locations are dedicated to helping researchers and
clinicians make a greater impact on science and health
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue’s InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. UltiMapper™ kits are fully optimized mIHC panels that provide uninhibited co-localization of multiple markers for deep single-cell phenotyping.
PromoCell is the premier manufacturer of cell culture products. PromoCell offers broad range of human primary cells, stem cells and blood cells, optimized cell culture media, and a comprehensive line of cell biology research products. Our cell culture products provide scientists with physiologically accurate models, and therefore enable them to obtain better research results. As the original manufacturer, PromoCell is committed to the highest possible ethical and legal standards
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas.
HalioDx is an immuno-oncology diagnostic company providing oncologists and Biopharma with first-in-class immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
For its Biopharma partners, HalioDx has developed the Immunogram, a clinical research platform allowing multimodal analysis to understand the tumor microenvironment. It integrates Immunoscore® assays, innovative technologies like Multiplex Spatial Tissue Analysis (Brightplex®) and molecular testing (NGS, Immunosign® Gene Expression Signatures).
Marks & Clerk are committed to providing exceptional intellectual property advice around the
world, helping you to navigate the complexities of IP, patents, trade marks and design protection.
Innovation is the life-blood of business and it’s vital that you do not overlook the need to protect your
intellectual property. From the capture of an idea, to the enforcement or defence of rights in disputes
Marks & Clerk is your expert partner to ensure your IP is protected and fully exploited. Today’s local
is tomorrow’s global – and with our diverse team of practitioners, you’re always supported by a
network of experts.
PHC Holdings Corporation is a global healthcare company with its products and services used in more than 125 countries. Subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia and LSI Medience Corporation. The company develops, manufactures, sells and services medical equipment and solutions across the diabetes management, diagnostics, life sciences and healthcare services. Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics. URL: www.phchd.com
Crown Bioscience is a cutting edge technology company providing drug discovery and services in oncology. Our diverse preclinical platform including in vitro, in vivo, ex vivo, and in silico models enables clients around the world to deliver superior clinical candidates through thorough dissection of drug mechanism of action and biomarker discovery.
Imaging Endpoints (IE) is an imaging research and core laboratory that provides comprehensive imaging CRO services and technology solutions. IE is one of the largest iCROs globally and is widely recognized for conducting the industry’s most complex trials. IE’s experience spans hundreds of successful trials across all phases of development, including the most high-profile, global registration trials. IE also specializes in novel imaging technologies such as radiomics where the company is the industry leader.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
Aquila BioMedical, a Concept Life Sciences company, is an innovative, preclinical contract research organisation, offering clients world-leading research expertise in immunology, immuno-oncology, neuroscience and specialist multiplex histology.
We offer customised and tailored services combining advanced models with protocolled techniques. The result? High-value data allowing you to define the efficacy and the mechanism of action of drug/antibody candidates. Partner with us to benefit from expert advice and interpretation of data from superior and experienced scientists.
From research to therapy, Horizon Discovery drives the application of gene editing and gene modulation. Innovative tools and services enable scientists to gain a greater understanding of the genetic drivers behind disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.
Mi-mAbs is an innovative integrated immunotechnology (a consortium) center designed to accelerate the development of new immunotherapy antibodies (mAbs, ADC, Bi-specifics) against cancer and inflammatory diseases. Open to the best targets of academic and industrial research, Mi-mAbs generates antibodies and validate them. Mim-Abs, a multi-disciplinary team, involving experts in hybridoma, molecular biology, biochemistry, immunochemistry and in vitro/in vivo immunopharmacology.
KDBIO is the European distributor for the FiberCell hollow fibre bioreactor enabling mAb production in the range 100mg to grams. This system fits in an incubator and supports continuous culture of hybridomas, CHO or HEK cells at very high cell density. Cell-secreted products are harvested at 50-100X the concentration of flask culture media with “in-vivo like” culture conditions favouring the correct folding, assembly and uniform glycosylation of “difficult-to-express” proteins. Manufacturer: FiberCell Systems, USA. www.kdbio.com
At Synthace, we harness the power of the digital world to empower scientists to unlock the potential of biology for the benefit of humankind and our environment.Our software platform, Antha, supports some of the world’s most visionary biology companies to achieve their dreams in transforming the biological research model.We have partnered with Microsoft, Merck, Oxford Biomedica, Cambridge Consultants and the Cell and Gene Therapy Catapult to optimise their research processes and unleash the full potential of their hardware.